(Q34475825)

2 August 2017

1 reference

title

Physiology and healing dynamics of chronic cutaneous wounds (English)

1 reference

2 August 2017

0 references

Stadelmann WK

1

1 reference

2 August 2017

Digenis AG

series ordinal

2

1 reference

2 August 2017

Tobin GR

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

The American Journal of Surgery

2 August 2017

1 reference

2 August 2017

176

1 reference

2 August 2017

2A Suppl

1 reference

2 August 2017

26S-38S

1 reference

Wound infection. A failure of wound healing caused by an imbalance of bacteria

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

The role of growth factors in wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Anaerobic metabolism and wound healing: An hypothesis for the initiation and cessation of collagen synthesis in wounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Analysis of explanted silicone implants: a report of 300 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

The biosynthesis of collagen and its disorders (first of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

The spatial and temporal quantification of myofibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Wound closure: evidence of cooperation between fibroblasts and collagen matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Covering by a flap induces apoptosis of granulation tissue myofibroblasts and vascular cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Fibroblasts, myofibroblasts, and wound contraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Wound healing--aiming for perfect skin regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Growth factors and cutaneous wound repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Growth factors and wound healing: biochemical properties of growth factors and their receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Growth factors and wound healing: Part II. Role in normal and chronic wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Growth factors and wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

The role of growth factors in wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Growth factors and wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Determination of endogenous cytokines in chronic wounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

The role of growth factors in the healing of chronic wounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Safety and effect of topical recombinant human interleukin-1beta in the management of pressure sores

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Enhancement of wound healing by topical treatment with epidermal growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Effects of recombinant human growth hormone on donor-site healing in severely burned children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Platelet-derived growth factor BB for the treatment of chronic pressure ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Regulation of collagen synthesis and messenger RNA levels in normal and hypertrophic scar fibroblasts in vitro by interferon alfa-2b.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Alteration in cell morphology triggers transforming growth factor-beta 1, collagenase, and tissue inhibitor of metalloproteinases-I expression in normal and hypertrophic scar fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

The response of burn scars to intralesional verapamil. Report of five cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Treatment of scars: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900183-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9610(98)00183-4

1 reference

2 August 2017

1 reference